JP2007503473A5 - - Google Patents

Download PDF

Info

Publication number
JP2007503473A5
JP2007503473A5 JP2006533699A JP2006533699A JP2007503473A5 JP 2007503473 A5 JP2007503473 A5 JP 2007503473A5 JP 2006533699 A JP2006533699 A JP 2006533699A JP 2006533699 A JP2006533699 A JP 2006533699A JP 2007503473 A5 JP2007503473 A5 JP 2007503473A5
Authority
JP
Japan
Prior art keywords
composition
opioid analgesic
analgesic
group
opioid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006533699A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007503473A (ja
Filing date
Publication date
Priority claimed from US10/459,911 external-priority patent/US7064140B2/en
Application filed filed Critical
Publication of JP2007503473A publication Critical patent/JP2007503473A/ja
Publication of JP2007503473A5 publication Critical patent/JP2007503473A5/ja
Pending legal-status Critical Current

Links

JP2006533699A 2003-06-12 2004-06-10 N−アシル化4−ヒドロキシフェニルアミン誘導体およびカフェインを含む相乗的組み合わせ Pending JP2007503473A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/459,911 US7064140B2 (en) 2002-11-12 2003-06-12 Synergistic combinations including N-acylated 4-Hydroxyphenylamine derivatives and caffeine
PCT/US2004/018514 WO2004110440A1 (en) 2003-06-12 2004-06-10 Synergistic combinations including n-acylated 4-hydroxyphenylamine derivatives and caffeine

Publications (2)

Publication Number Publication Date
JP2007503473A JP2007503473A (ja) 2007-02-22
JP2007503473A5 true JP2007503473A5 (enExample) 2007-06-21

Family

ID=33510895

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006533699A Pending JP2007503473A (ja) 2003-06-12 2004-06-10 N−アシル化4−ヒドロキシフェニルアミン誘導体およびカフェインを含む相乗的組み合わせ

Country Status (9)

Country Link
US (1) US7064140B2 (enExample)
EP (1) EP1635825B1 (enExample)
JP (1) JP2007503473A (enExample)
AT (1) ATE409478T1 (enExample)
AU (1) AU2004247138B2 (enExample)
CA (1) CA2531829A1 (enExample)
DE (1) DE602004016848D1 (enExample)
ES (1) ES2315679T3 (enExample)
WO (1) WO2004110440A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053012A2 (en) * 2004-11-10 2006-05-18 Trinity Laboratories, Inc. Novel pharmaceutical compositions for treating acquired chronic pain and associated dysphoria
US8026266B2 (en) * 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的2-胺基萘滿之於製造用於預防、減緩及/或治療各種類型疼痛之藥物上的用途
WO2009021058A2 (en) 2007-08-06 2009-02-12 Trinity Labortories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554636A (en) * 1995-04-21 1996-09-10 Lsu Medical Center Foundation N-acylated 4-hydroxphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
US6864271B2 (en) * 2002-11-12 2005-03-08 The Foundation For The Lsu Health Sciences Center Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives

Similar Documents

Publication Publication Date Title
JP2003528819A5 (enExample)
JP2007508325A5 (enExample)
JP2008534564A5 (enExample)
RU2009125597A (ru) Пролекарства и способы их получения и применения
Toll et al. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications
JP2010511717A5 (enExample)
KR101343395B1 (ko) 부프레노르핀 유사체
JP2009167214A5 (enExample)
JP2011519930A5 (enExample)
JP2012519675A5 (enExample)
CA2446738A1 (en) Abuse-resistant opioid dosage form
CO5590940A2 (es) Antagonistas de endotelina en un metodo y composicion para potenciar un analgesico opiaceo
JP2010189403A5 (enExample)
CA2463938A1 (en) Polymer conjugates of opioid antagonists
JP2005247859A5 (enExample)
JP6279547B2 (ja) オピオイド誘発性有害薬力学的応答を治療するためのシステムおよび方法
CA2547334A1 (en) Methods and compositions for deterring abuse of opioid containing dosage forms
RU2000119778A (ru) Комбинации агонист/антагонист опиоида
JP2009541320A5 (enExample)
JP2005530798A5 (enExample)
CA2323805A1 (en) Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
RU2009141615A (ru) Композиции и способы профилактики и лечения зависимости
AR077394A1 (es) Metodos para tratar nvpa ynvpo con composiciones de ondansetron de liberacion prolongada
RU2007149044A (ru) Твердые лекарственные формы наркотических лекарственных средств с улучшенным всасыванием при трансбуккальном введении
CA2544648A1 (en) Analgesic compounds, their synthesis and pharmaceutical compositions containing them